Humoral immune response against Borna disease virus (BDV) in experimentally and naturally infected cats

Veterinary Immunology and Immunopathology

Volumn 90, Issue 1-2, 2002, Pages 23-33

  Johansson, M ^a   Berg, M ^a   Berg, A L ^b  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Borna disease virus; Cat; ELISA; Immunoglobulin; Staggering disease

Indexed keywords

ANTIGEN P24; PROTEIN P40; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BORNA DISEASE; BORNA DISEASE VIRUS; CAT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMORAL IMMUNITY; IMMUNOFLUORESCENCE; NONHUMAN; SERUM;

BORNA DISEASE VIRUS; FELIDAE; FELIS CATUS;

EID: 0036877095     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(02)00226-X     Document Type: Article

References (38)

1. Berg A.-L., Dörries R., Berg M. Borna disease virus infection in racing horses with behavioral and movement disorders. Arch. Virol. 144(3):1999a;547-559.
2. Berg A.-L., Johannisson A., Johansson M., Hein A., Berg M., Dörries R. Peripheral and intracerebral T cell immune response in cats naturally infected with Borna disease virus. Vet. Immunol. Immunopathol. 68:1999b;241-253.
3. Berg M., Ehrenborg C., Blomberg J., Pipkorn R., Berg A.-L. Two domains of the Borna disease virus p40 protein are required for interaction with the p24 protein. J. Gen. Virol. 79:1998;12.
4. Berg M., Johansson M., Montell H., Berg A.-L. Wild birds as a possible natural reservoir of Borna disease virus. Epidemiol. Infect. 127:2001;173-178.
5. Bornand J.V., Fatzer R., Melzer K., Jmaa D.G., Caplazi P., Ehrensperger F. A case of Borna Disease in a cat. Eur. J. Vet. Pat. 4:1998;33-35.
6. Briese T., Hatalski C.G., Kliche S., Park Y.S., Lipkin W.I. Enzyme-linked immunosorbent assay for detecting antibodies to Borna disease virus-specific proteins. J. Clin. Microbiol. 33(2):1995;348-351.
7. Carbone K.M., Rubin S.A., Sierra-Honigmann A.M., Lederman H.M. Characterization of a glial cell line persistently infected with Borna disease virus (BDV): influence of neurotrophic factors on BDV protein and RNA expression. J. Virol. 67(3):1993;1453-1460.
8. de la Torre J.C. Molecular biology of Borna disease virus: prototype of a new group of animal viruses. J. Virol. 68:1994;12.
9. Dietzschold B., Kao M., Zheng Y.M., Chen Z.Y., Maul G., Fu Z.F., Rupprecht C., Koprowski H. Delineation of putative mechanisms involved in the antibody-mediated clearance of rabies virus from the central nervous system. Proc. Natl. Acad. Sci. U.S.A. 89:1992;7252-7256.
10. Gosztonyi G., Ludwig H. Borna disease - neuropathology and pathogenesis. Curr. Top. Microbiol. Immunol. 190:1995;39-73.
11. Hatalski C.G., Kliche S., Stitz L., Lipkin W.I. Neutralizing antibodies in Borna disease virus-infected rats. J. Virol. 69(2):1995;741-747.
12. Hatalski C.G., Hickey W.F., Lipkin W.I. Humoral immunity in the central nervous system of Lewis rats infected with Borna disease virus. J. Neuroimmunol. 90(2):1998a;128-136.
13. Hatalski C.G., Hickey W.F., Lipkin W.I. Evolution of the immune response in the central nervous system following infection with Borna disease virus. J. Neuroimmunol. 90(2):1998b;137-142.
14. Hickey W.F. Leukocyte traffic in the central nervous system: the participants and their roles. Semin. Immunol. 11:1999;125-137.
15. Huebner J., Bode L., Ludwig H. Borna disease virus infection in FIV-positive cats in Germany. Vet. Rec. 149:2001;152.
16. Katz J.B., Alstad D., Jenny A.L., Carbone K.M., Rubin S.A., Waltrip R.W. Clinical, serologic, and histopathologic characterization of experimental Borna disease in ponies. J. Vet. Diagn. Invest. 10(4):1998;338-343.
17. Levine B., Hardwick J.M., Trapp B.D., Crawford T.O., Bollinger R.C., Griffin D.E. Andibody-mediated clearance of alpha-virus infection from neurons. Science. 254:1991;856-859.
18. Ludwig H., Bode L. Borna disease virus: new aspects on infection, disease, diagnosis and epidemiology. Rev. Sci. Tech. 19(1):2000;259-288.
19. Lundgren A.-L., Ludwig H. Clinically diseased cats with non-suppurative meningoencephalomyelitis have Borna disease virus-specific antibodies. Acta Vet. Scand. 34(1):1993;101-103.
20. Lundgren A.-L., Lindberg R., Ludwig H., Gosztonyi G. Immunoreactivity of the central nervous system in cats with a Borna disease-like meningoencephalomyelitis (staggering disease). Acta Neuropathol. 1995(90):1995a;184-193.
21. Lundgren A.-L., Zimmermann W., Bode L., Czech G., Gosztonyi G., Lindberg R., Ludwig H. Staggering disease in cats: isolation and characterization of the feline Borna disease virus. J. Gen. Virol. 76:1995b;2215-2222.
22. Lundgren A.L., Johannisson A., Zimmermann W., Bode L., Rozell B., Muluneh A., Lindberg R., Ludwig H. Neurological disease and encephalitis in cats experimentally infected with Borna disease virus. Acta Neuropathol. 93:1997;391-401.
23. Nakamura Y., Watanabe M., Kamitani W., Taniyama H., Nakaya T., Nishimura Y., Tsujimoto H., Machida S., Ikuta K. High prevalence of Borna disease virus in domestic cats with neurological disorders in Japan. Vet. Microbiol. 70:1999;153-169.
24. Nowotny N., Weissenbock H. Description of feline nonsuppurative meningoencephalomyelitis (staggering disease) and studies of its etiology. J. Clin. Microbiol. 33:1995;1668-1669.
25. Patrick A.K., Lindsley M.D., Rodriguez M. Differential pathogenesis between mouse strains resistant and susceptible to Theiler's virus-induced demyelination. Semin. Virol. 1:1990;281-288.
26. Rand J.S., Parent J., Jacobs R., Johnson R. Reference intervals for feline cerebrospinal fluid: Biochemical and serological variables, IgG concentration and electrophoretic fractionation. Am. J. Vet. Res. 51(7):1990;1049-1054.
27. Reeves N.A., Helps C.R., Gunn-Moore D.A., Blundell C., Finnemore P.L., Pearson G.R., Harbour D.A. Natural Borna disease virus infection in cats in the United Kingdom. Vet. Rec. 143(19):1998;523-526.
28. Richt J.A., Grabner A., Herzog S. Borna disease in horses. Vet. Clin. North Am. Equine Pract. 16(3):2000;579-595.
29. Rott R., Becht H. Natural and experimental Borna disease in animals. Curr. Top. Microbiol. Immunol. 190:1995;17-30.
30. Schneemann A., Schneider P.A., Lamb R.A., Lipkin W.I. The remarkable coding strategy of Borna disease virus: a new member of the nonsegmented negative strand RNA viruses. Virology. 210(1):1995;1-8.
31. Staeheli P., Sauder C., Hausmann J., Ehrensperger F., Schwemmle M. Epidemiology of Borna disease virus. J. Gen. Virol. 81:2000;2123-2135.
32. Stitz L., Dietzschold B., Carbone K.M. Immunopathogenesis of Borna disease. Curr. Top. Microbiol. Immunol. 190:1995;75-92.
33. Stitz L., Noske K., Planz O., Furrer E., Lipkin W.I., Bilzer T. A functional role for neutralizing antibodies in Borna disease: influence on virus tropism outside the central nervous system. J. Virol. 72(11):1998;8884-8892.
34. Svenda M., Hjertner B., Linné T., Berg M. Both the P and V proteins of the porcine rubulavirus LPMV interact with the NP protein via their respective C-terminal unique parts. Virus Res. 83:2002;31-41.
35. Watanabe M., Zhong Q., Kobayashi T., Kamitani W., Tomonaga K., Ikuta K. Molecular ratio between Borna disease viral-p40 and-p24 proteins in infected cells determined by quantitative antigen capture ELISA. Microbiol. Immunol. 44:2000;765-772.
36. Wehner T., Ruppert A., Herden C., Frese K., Becht H., Richt J.A. Detection of a novel Borna disease virus-encoded 10 kDa protein in infected cells and tissues. J. Gen. Virol. 78:1997;2459-2466.
37. Weissenböck H., Novotny N., Zoher J. Feline meningoencephalomyelitis (staggering disease) in Österreich. Wien. Tierarztl. Mschr. 81:1994;195-201.
38. Wright K.E., Buchmeier M.J. Antiviral antibodies attenuate T-cell-mediated immunopathology following acute lymphocytic choriomeningitis virus infection. J. Virol. 65:1991;3001-3006.